SpectraScience: Innovations in Cancer Detection
SpectraScience has developed patented platform technology that diagnoses colorectal cancer, which has a market size of $1, 442.6 million.
gastroenterology
Diagnovus Focused on Delivering Personalized Diagnostic Information and Services to Physicians Treating Patients Suffering from Rare Diseases
Diagnovus is a specialized molecular diagnostic company, focused on delivering personalized diagnostic information and services to physicians treating patients suffering from rare, orphan and less frequent diseases. We are privileged for the opportunity to serve patients and the physicians treating them.